Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro

Veterinary Immunology and Immunopathology

Volumn 124, Issue 1-2, 2008, Pages 120-131

  Im Hof, Michelle ^a   Williamson, Lina ^b   Summerfield, Artur ^c   Balmer, Vreni ^a   Dutoit, Virginie ^b   Kandimalla, Ekambar R ^d   Yu, Dong ^d   Zurbriggen, Andreas ^a   Doherr, Marcus G ^a   Peel, John ^b   Roosje, Petra J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Centre de Recherche Sante Animale   (Switzerland)

^c INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^d HYBRIDON INC   (United States)

Author keywords

Canine lymphocyte proliferation; Cytokines; Flow cytometry; Immunomodulatory oligonucleotides; TLR9 agonists; Toll like receptor 9

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD5 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CONCANAVALIN A; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

CANIS FAMILIARIS; MUS;

EID: 44249117316     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.03.002     Document Type: Article

References (31)

1. M. Akdis Healthy immune response to allergens: T regulatory cells and more Curr. Opin. Immunol. 18 2006 738 744
2. J. Brochier C. Samarut J.P. Gueho J.P. Revillard T-dependence of human B lymphocyte proliferative response to mitogens Int. Arch. Allergy Appl. Immunol. 51 1976 101 116
3. L. Guzylack-Piriou C. Balmelli K.C. McCullough A. Summerfield Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12 Immunology 112 2004 28 37
4. T. Hayashi E. Raz TLR9-based immunotherapy for allergic disease Am. J. Med. 119 2006 897.e1 897.e6
5. H. Hemmi O. Takeuchi T. Kawai T. Kaisho S. Sato H. Sanjo M. Matsumoto K. Hoshino H. Wagner K. Takeda S. Akira A toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
6. G. Ignacio S. Nordone K.E. Howard G.A. Dean Toll-like receptor expression in feline lymphoid tissues Vet. Immunol. Immunopathol. 106 2005 229 237
7. A. Iwasaki R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat. Immunol. 5 2004 987 995
8. V.V. Jain K. Kitagaki T. Businga I. Hussain C. George P. O'Shaughnessy J.N. Kline CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma J. Allergy Clin. Immunol. 110 2002 867 872
9. P. Johansen G. Senti J.M. Martinez Gomez T. Storni B.R. von Beust B. Wuthrich A. Bot T.M. Kundig Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy Clin. Exp. Allergy 35 2005 1591 1598
10. E.R. Kandimalla D. Yu Q. Zhao S. Agrawal Effect of chemical modifications of cytosine and guanosine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships Bioorg. Med. Chem. 9 2001 807 813
11. E.R. Kandimalla L. Bhagat D. Wang D. Yu F.G. Zhu J. Tang H. Wang P. Huang R. Zhang S. Agrawal Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction progiles Nucleic Acids Res. 31 2003 2393 2400
12. E.R. Kandimalla L. Bhagat F.G. Zhu D. Yu Y.P. Cong D. Wang J.X. Tang J.Y. Tang C.F. Knetter E. Lien S. Agrawal A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif Proc. Natl. Acad. Sci. U.S.A. 100 2003 14303 14308
13. E.R. Kandimalla L. Bhagat Y. Li D. Yu D. Wang Y.P. Cong S.S. Song J.X. Tang T. Sullivan S. Agrawal Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists Proc. Natl. Acad. Sci. U.S.A. 102 2005 6925 6930
14. J.N. Kline T.J. Waldschmidt T.R. Businga J.E. Lemish J.V. Weinstock P.S. Thorne A.M. Krieg Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma J. Immunol. 160 1998 2555 2559
15. D.M. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides Nat. Rev. Immunol. 4 2004 249 258
16. D.M. Klinman A.K. Yi S.L. Beaucage J. Conover A.M. Krieg CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Proc. Natl. Acad. Sci. U.S.A. 93 1996 2879 2883
17. A.M. Krieg Now i know my CpGs Trends Microbiol. 9 2001 249 252
18. A.M. Krieg Therapeutic potential of Toll-like receptor 9 activation Nat. Rev. Drug Discov. 5 2006 471 484
19. E. Latz A. Schoenemeyer A. Visintin K.A. Fitzgerald B.G. Monks C.F. Knetter E. Lien N.J. Nilsen T. Espevik D.T. Golenbock TLR9 signals after translocating from the ER to CpG DNA in the lysosome Nat. Immunol. 5 2004 190 198
20. Y. Li E.R. Kandimalla D. Yu S. Agrawal Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice Int. Immunopharmacol. 5 2005 981 991
21. C. Pasare R. Medzhitov Toll-like receptors: balancing host resistance with immune tolerance Curr. Opin. Immunol. 15 2003 677 682
22. C. Pasare R. Medzhitov Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells Sci. NY 299 2003 1033 1036
23. P.F. Piguet H.K. Dewey P. Vassalli Induction or suppression of B cell proliferation and differentiation by phytohemagglutinin or concanavalin A in mouse spleen cell cultures J. Immunol. 117 1976 1817 1823
24. M.R. Putta F. Zhu Y. Li L. Bhagat Y. Cong E.R. Kandimalla S. Agrawal Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications Nucleic Acids Res. 34 2006 3231 3238
25. F. Romagne Current and future drugs targeting one class of innate immunity receptors: the toll-like receptors Drug Discov. Today 12 2007 80 87
26. K.J. Stacey M.J. Sweet D.A. Hume Macrophages ingest and are activated by bacterial DNA J. Immunol. 157 1996 2116 2122
27. H. Wagner Bacterial CpG DNA activates immune cells to signal infectious danger Adv. Immunol. 73 1999 329 368
28. C. Walker C. Zuany-Amorim New trends in immunotherapy to prevent atopic diseases Trends Pharmacol. Sci. 22 2001 84 90
29. C.M. Wernette B.F. Smith Z.L. Barksdale R. Hecker H.J. Baker CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation Vet. Immunol. Immunopathol. 84 2002 223 236
30. A.K. Yi A.M. Krieg Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA J. Immunol. 161 1998 4493 4497
31. C. Zuany-Amorim J. Hastewell C. Walker Toll-like receptors as potential therapeutic targets for multiple diseases Nat. Rev. Drug Discov. 1 2002 797 807